We just received data on a new analyst forecast for $IFRX. Guggenheim gave a rating of 'Buy' for $IFRX.
$IFRX Analyst Ratings
Wall Street analysts have issued reports on $IFRX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 03/26/2025
To track analyst ratings and price targets for $IFRX, check out Quiver Quantitative's $IFRX forecast page.
$IFRX Hedge Fund Activity
We have seen 15 institutional investors add shares of $IFRX stock to their portfolio, and 19 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 1,370,035 shares (+205.1%) to their portfolio in Q4 2024, for an estimated $3,383,986
- EVERSEPT PARTNERS, LP removed 1,129,335 shares (-69.6%) from their portfolio in Q4 2024, for an estimated $2,789,457
- IKARIAN CAPITAL, LLC removed 704,987 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,741,317
- NORTHERN TRUST CORP added 634,045 shares (+1933.1%) to their portfolio in Q4 2024, for an estimated $1,566,091
- WOODLINE PARTNERS LP removed 173,586 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $265,586
- OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) removed 172,287 shares (-21.6%) from their portfolio in Q4 2024, for an estimated $425,548
- UBS GROUP AG added 67,441 shares (+inf%) to their portfolio in Q4 2024, for an estimated $166,579
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.